SkinBioTherapeutics (SBTX.LSE) Q2 2026 Earnings

8JunConfirmed
Q4 2024
Q1 2025
Q4 2025
Q2 2026
-0.44
-0.4
-0.36
-0.31

Details

Expected EPS
N/A
Actual EPS
-0.3131404736
Surprise EPS
-0.31
Surprise Percent
+∞%

Description

SkinBioTherapeutics (SBTX.LSE) has reported earnings of -0.3131404736 per share for Q2 2026.

0 Comments

Share your thoughts